​
Login / Signup
Jitender Monga
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Transcription Factor
Induced Apoptosis
Hepatitis C Virus
Pi K Akt
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jitender Monga
,
Frederick Valeriote
,
Clara Hwang
,
Shirish M Gadgeel
,
Jagadananda Ghosh
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells.
Molecular cancer therapeutics
22 (3) (2023)
Jitender Monga
,
Frederick Valeriote
,
Clara Hwang
,
Shirish M Gadgeel
,
Jagadananda Ghosh
Daclatasvir, an antiviral drug, downregulates Tribbles 2 pseudokinase and re-sensitizes enzalutamide resistant prostate cancer cells.
Molecular cancer therapeutics
(2023)
Jitender Monga
,
Frederick Valeriote
,
Clara Hwang
,
Shirish M Gadgeel
,
Jagadananda Ghosh
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells.
Molecular cancer therapeutics
22 (3) (2023)